Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04LZN
|
||||
| Former ID |
DNC008817
|
||||
| Drug Name |
8-Bromo-9-cyclobutyl-9H-adenine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530014] | ||
| Formula |
C9H10BrN5
|
||||
| Canonical SMILES |
C1CC(C1)N2C3=C(C(=NC=N3)N)N=C2Br
|
||||
| InChI |
1S/C9H10BrN5/c10-9-14-6-7(11)12-4-13-8(6)15(9)5-2-1-3-5/h4-5H,1-3H2,(H2,11,12,13)
|
||||
| InChIKey |
ODVHXPRTEZXIFW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [530014] | |
| Adenosine A1 receptor | Target Info | Inhibitor | [530014] | ||
| Adenosine A2b receptor | Target Info | Inhibitor | [530014] | ||
| Adenosine A2a receptor | Target Info | Inhibitor | [530014] | ||
| KEGG Pathway | cGMP-PKG signaling pathway | ||||
| cAMP signaling pathway | |||||
| Sphingolipid signaling pathway | |||||
| Neuroactive ligand-receptor interaction | |||||
| Morphine addictionhsa04015:Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Vascular smooth muscle contraction | |||||
| Alcoholismhsa04015:Rap1 signaling pathway | |||||
| Parkinson's disease | |||||
| Alcoholism | |||||
| Pathway Interaction Database | C-MYB transcription factor networkhif2pathway:HIF-2-alpha transcription factor network | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.